Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07174076 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease

StatusRecruiting
PhasePhase 4
SponsorBin Cao
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Bin Cao
4 trials monitored
See all monitored trials
The goal of this clinical trial is to learn if cordyceps sinesis capsule (Bailiing Capsule) works to prevent the recurrence of microbiologically cured mycobacterium avium complex pulmonary disease in adults. The main questions it aims to answer are: Does cordyceps sinesis capsule (Bailiing Capsule) prevents the recurrence of mycobacterium avium complex pulmonary disease in adults? Researchers will compare cordyceps sinesis capsule (Bailiing Capsule) to a placebo (a look-alike substance that contains no drug) to see if cordyceps sinesis capsule helps to prevent the recurrence of mycobacterium avium complex pulmonary disease. Participants will: Take cordyceps sinesis capsule (Bailiing Capsule) or a placebo (a look-alike substance that contains no drug) for 12 months, both are administered every day. Visit the clinic once every 3 months for checkups and tests. Take online questionnaires every month.
Trial Details
NCT Number NCT07174076
Lead Sponsor Bin Cao
Collaborators: China-Japan Friendship Hospital, Shanghai Pulmonary Hospital, Shanghai, China, Jiangxi Chest Hospital, Guangzhou Chest Hospital., Anhui Chest Hospital, Beijing Chest Hospital, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions
(from sponsor)		 Mycobacterium Avium Complex Pulmonary Disease
Related terms Recurrence
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov